VENASEAL CLOSURE SYSTEM

Agent, Occluding, Vascular, Permanent

FDA Premarket Approval P140018

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the venaseal closure system. This device is indicated for the permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein (gsv), through endovascular embolization with coaptation. Venaseal is intended for use in adults with clinically symptomatic venous reflux as diagnosed by duplex ultrasound (dus).

DeviceVENASEAL CLOSURE SYSTEM
Classification NameAgent, Occluding, Vascular, Permanent
Generic NameAgent, Occluding, Vascular, Permanent
ApplicantMEDTRONIC VASCULAR INC
Date Received2014-08-25
Decision Date2015-02-20
Notice Date2015-02-20
PMAP140018
SupplementS
Product CodePJQ
Docket Number15M-0690
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address MEDTRONIC VASCULAR INC 3033 Campus Drive plymouth, MN 55441
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140018Original Filing
S036 2022-11-29 30-day Notice
S035 2022-10-12 30-day Notice
S034 2022-08-15 30-day Notice
S033
S032 2022-04-29 Real-time Process
S031 2022-01-21 30-day Notice
S030 2021-11-30 30-day Notice
S029
S028 2021-09-23 30-day Notice
S027
S026
S025 2021-04-23 Special (immediate Track)
S024
S023 2021-02-25 30-day Notice
S022
S021 2020-10-19 Real-time Process
S020 2020-08-24 30-day Notice
S019 2020-03-10 Special (immediate Track)
S018 2019-10-28 Normal 180 Day Track
S017 2019-09-25 Real-time Process
S016 2019-08-09 30-day Notice
S015 2019-05-24 30-day Notice
S014 2018-11-16 30-day Notice
S013 2018-09-24 30-day Notice
S012 2018-08-10 30-day Notice
S011 2018-03-27 30-day Notice
S010 2018-03-05 30-day Notice
S009 2018-02-26 30-day Notice
S008 2017-08-04 Normal 180 Day Track
S007 2017-06-13 Special (immediate Track)
S006 2017-05-18 Normal 180 Day Track No User Fee
S005 2016-11-01 30-day Notice
S004 2016-09-07 Normal 180 Day Track No User Fee
S003 2016-07-26 30-day Notice
S002 2016-06-27 30-day Notice
S001 2015-07-28 Real-time Process

NIH GUDID Devices

Device IDPMASupp
10884521539921 P140018 000
20643169986262 P140018 006
00763000240776 P140018 018

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.